Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study (Q36953356)

17 August 2017

1 reference

title

Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study (English)

1 reference

surface plasmon resonance

17 August 2017

0 references

1 reference

inferred from title

molecular interaction

1 reference

James Beattie

1

1 reference

17 August 2017

Kirsten Phillips

2

1 reference

17 August 2017

John H Shand

3

1 reference

17 August 2017

Malgorzata Szymanowska

4

1 reference

17 August 2017

David J Flint

5

1 reference

17 August 2017

Gordon J Allan

6

1 reference

17 August 2017

publication date

25 September 2007

1 reference

Molecular and Cellular Biochemistry

17 August 2017

published in

1 reference

17 August 2017

volume

307

1 reference

17 August 2017

issue

1-2

1 reference

17 August 2017

page(s)

221-236

1 reference

Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11010-007-9601-8

Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11010-007-9601-8

Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin

21 January 2018

1 reference

12 December 2020

Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms

1 reference

12 December 2020

Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding.

1 reference

12 December 2020

Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats

1 reference

12 December 2020

Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity

1 reference

12 December 2020

Human insulin-like growth factor binding protein-6 is O-glycosylated

1 reference

12 December 2020

Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3.

1 reference

12 December 2020

Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface

1 reference

12 December 2020

Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor

1 reference

12 December 2020

Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion

1 reference

12 December 2020

Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth

1 reference

12 December 2020

Analysis of mass transport-limited binding kinetics in evanescent wave biosensors

1 reference

12 December 2020

Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).

1 reference

12 December 2020

Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix

1 reference

12 December 2020

Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation

1 reference

12 December 2020

Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.

1 reference

12 December 2020

Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding

1 reference

12 December 2020

Biosensor analysis of the molecular interactions of pentosan polysulfate and of sulfated glycosaminoglycans with immobilized elastase, hyaluronidase and lysozyme using surface plasmon resonance (SPR) technology

1 reference

12 December 2020

The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain

1 reference

12 December 2020

Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions

1 reference

12 December 2020

Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation

1 reference

12 December 2020

A rapid, non-radioactive method for the detection of insulin-like growth factor binding proteins by Western ligand blotting

1 reference

12 December 2020

Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5

1 reference

12 December 2020

Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5.

1 reference

12 December 2020

Characterization of a set of HIV-1 protease inhibitors using binding kinetics data from a biosensor-based screen

1 reference

12 December 2020

Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3

1 reference

12 December 2020

The role of glycosylation in the action of IGFBP-3

1 reference

12 December 2020

Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

1 reference

12 December 2020

Determination of kinetic data using surface plasmon resonance biosensors

1 reference

12 December 2020

Differential dissociation kinetics explain the binding preference of insulin-like growth factor binding protein-6 for insulin-like growth factor-II over insulin-like growth factor-I.

1 reference

12 December 2020

Biosensor Analysis of Receptor-Ligand Interactions

1 reference

12 December 2020

Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells

1 reference

12 December 2020

Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor

1 reference

12 December 2020

Improved method for the immobilization of heparin

1 reference

12 December 2020

Control of Insulin-Like Growth Factor Binding Protein-5 Protease Synthesis and Secretion by Human Fibroblasts and Porcine Aortic Smooth Muscle Cells

1 reference

12 December 2020

Ligand rebinding: self-consistent mean-field theory and numerical simulations applied to surface plasmon resonance studies

1 reference

12 December 2020

Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I.

1 reference

12 December 2020

Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions

1 reference

12 December 2020

Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I

1 reference

12 December 2020

Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization

1 reference

12 December 2020

A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts

1 reference

12 December 2020

Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain

1 reference

12 December 2020

Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast

1 reference

12 December 2020

Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining

1 reference

12 December 2020

BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains

1 reference

12 December 2020

Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes

1 reference

12 December 2020

Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation

1 reference

12 December 2020

Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland

1 reference

12 December 2020

Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action

1 reference

12 December 2020

Survey of the year 2003 commercial optical biosensor literature

1 reference

12 December 2020

QSAR studies applied to the prediction of antigen-antibody interaction kinetics as measured by BIACORE.

1 reference

12 December 2020

Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions

1 reference

12 December 2020

Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis

1 reference

12 December 2020

10.1007/S11010-007-9601-8

Identifiers

DOI

1 reference

17 August 2017

1 reference